You guys are a good team. I can tell I could tell you work together.

If you want to stay with me before. Go ahead. Yeah.

As her student was in the room, we're having a conversation where we're having partial sentences at each other, but we understand exactly what we're saying.

Welcome back to the Curb Siders, the Internal Medicine Podcast that uses expert interviews to bring you clinical pearls and practice changing knowledge.

I'm Dr. Matthew Wato. Here without my normal co-host, Dr. Stewart Kent Brigham and Dr. Paul Nelson Williams. Unfortunately, they couldn't make it tonight, but we have two great guests and a great conversation on Hepatitis C.

So I'm going to get right into the guest introductions here. Our first guest is Dr. Gina Simon-Sini. She's been on the show twice before. She's an associate professor of medicine at Temple University Hospital.

She attended medical school at the Lewis Cat School of Medicine at Temple, where she completed her residency training, as well as a year as a chief resident.

Dr. Simon-Sini went on to complete an HIV fellowship at the AIDS Healthcare Foundation and has recently completed her Master's of Public Health at Temple University.

Dr. Simon-Sini's interests include HIV Care, the treatment of Hepatitis C Women's Health and LGBTQ Care, and we are especially happy to have her back on the show.

Our other guest is Dr. David Corrin. He is a board certified pharmacotherapy specialist and infectious diseases clinical pharmacist at Temple University Hospital.

Dr. Corrin graduated from Temple University School of Pharmacy and completed his pharmacy practice residency at Yale New Haven Hospital and then completed an infectious diseases residency at the Cleveland Clinic.

Since returning to Philadelphia, Dr. Corrin has been the primary HIV pharmacist in both the infectious diseases and internal medicine-based HIV practices at Temple.

He additionally serves as a clinical educator in the areas of HIV and Hepatitis C, precepting for both the Temple University Pharmacy Residency Program and as an adjunct assistant clinical professor for the Temple University School Pharmacy.

David continues to practice in the multidisciplinary and collaborative practices at Temple with focuses on medical education, management, and access.

This discussion with David and Gina goes all through the basics of Hepatitis C and how it can be treated with the new direct acting, antiviral therapy.

And I think you're really going to enjoy this. It has a lot of great clinical pearls in there from both of our guests. So without further ado, here's my discussion with David and Gina.

This is Dr. Matthew Otto here with two great guests for this topic of Hepatitis C and how we can treat it in primary care.

Our first guest is Dr. Gina Simon-Ceney. She's an associate professor of medicine at Temple University Hospital coming back for her third appearance. Is that right Gina?

Yeah, it is actually. Yeah, you're becoming a regular on the show. That's great. Congratulations, Gina. I'm so happy for you.

And also also on the show tonight is Dr. David Keren. He is an infectious disease clinical pharmacist at Temple University Hospital and also an adjunct professor at the Temple University School of Pharmacy. Hi, David.

Hello, glad to be here. Yeah, thank you so much for coming on the show. We, you know, I actually, when Gina suggested that we have you on the show, I was like, that's a great idea. And we might be doing this for future topics as well.

Like in the hospital, it's always nice to have a pharmacist rounding with you. And I feel like this is like virtual rounds like me, you and Gina. And yeah, it's good. It's a well, well rounded team.

...